Approval · Notice of Compliance 33042 · 2024
MICRO CU: Notice of Compliance 33042
Issued April 11, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33042
- Date
- April 11, 2024
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to labels.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MICRO CU | Not yet assigned | — |
Medicinal ingredients
- CUPRIC SULFATE 0.4 MG per ML